Patients with HCC consistently displayed elevated fasting blood glucose concentration and enhanced hepatic abundance of MASH markers TGFB1 and COL1A1 in relation to control subjects (Table 1). This evidence concerns the gene COL1A1 and hepatocellular carcinoma.